A 28-year-old woman presented with a range of gastrointestinal adverse effects caused by Metformin. |
Treatment
The patient trialled RN Labs Berbersorb for insulin resistance for three weeks at a dose of 1 capsule per 500mg of Metformin. |
Outcome
The patient stated that she experienced a significant reduction in her gastrointestinal symptoms. However, when she tried to reduce the RN Labs Berbersorb dose, her gastrointestinal symptoms returned, although they were not as severe as they used to be. The patient said she was happy with the outcome and would continue taking 2 RN Labs Berbersorb capsules alongside her 1g of Metformin per night. |